Hepatitis C and Depressive Symptoms: Psychological and Social Factors Matter More Than Liver Injury

Abstract

Objective:

Given that the hepatitis C virus (HCV) crosses the blood-brain barrier, biological factors are commonly blamed for the high rates of mood disturbance in HCV-infected patients. However, no study assessing the potential contribution of psychosocial factors to depression in HCV has yet been conducted.

Methods:

A cross-sectional survey of 65 patients was undertaken to identify biological, psychological, and sociological contributions to depression. Biological, psychological, and sociological variables were tested for their association with depressive symptomatology as measured by the BDI-II. Separate analyses were conducted on health-related quality of life (HRQOL), as measured by the SF-36, in order to confirm findings in previous work.

Results:

Psychosocial variables assessed in the study, such as less social functioning, less religious faith, less ability to work, less salary, personal suicide attempt, worse reaction to diagnosis, and feeling “stressed out” were all associated with higher depression scores and lower HRQOL. Biological variables, including viral load, liver enzyme levels, INR, and stage of liver fibrosis on biopsy, were not associated with higher depression or lower HRQOL.

Conclusions:

The amount of disease as measured by laboratory abnormalities such as viral load, liver function tests, liver biopsy, and INR do not provide much useful information about a patient's depressive symptoms. Instead, these depressive symptoms are more influenced by psychological and social factors. Psychosocial support may therefore be beneficial to HCV patients.

Keywords

hepatitis C liver depression depressive disorder health-related quality of life

Get full access to this article

View all access options for this article.

References

Alter

Kruszon-Moran

Nainan

McQuillan

Gao

Moyer

Kaslow

Margolis

. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 1999; 341(8): 556–562.

Zdilar

Franco-Bronson

Buchler

Locala

Younossi

. Hepatitis C, interferon alpha, and depression. Hepatology 2000; 31(6): 1207–1211.

Golden

O'Dwyer

Conroy

. Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors. General Hospital Psychiatry 2005; 27(6): 431–438.

Ozkan

Corapcioglu

Balcioglu

Ertekin

Khan

Ozdemir

Karayun

Unsalver

Kocaman

Kaymakglu

Koroglu

. Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. International Journal of Psychiatry in Medicine 2006; 36(3): 283–297.

Johnson

Fisher

Fenaughty

Theno

. Hepatitis C virus and depression in drug users. American Journal of Gastroenterology 1998; 93(5): 785–789.

Tseng

O'Brien

Zhang

Kral

Ortiz-Conde

Lorvick

Busch

Edlin

. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology 2007; 46(3): 666–671.

Reichenberg

Gorman

Dieterich

. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: A 72 week prospective study. AIDS 2005; 19(Suppl 3): S174–S178.

Lee

Jamal

Regenstein

Perillo

. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Digestive Disease Science 1997; 42(1): 186–191.

Yates

Gleason

. Hepatitis C and depression. Depression and Anxiety 1998; 7(4): 188–193.

10.

Batey

. Managing hepatitis C. Unpublished guide for patients. 2003.

11.

Singh

Gayowski

Wagener

Marino

. Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clinical Transplantation 1997; 11(5 Pt 1): 406–411.

12.

Aronson

. Caring for the HIV-positive adult. Unpublished guide for internal medicine residents. 2003.

13.

Israelski

Prentiss

Lubega

Balmas

Garcia

Muhammad

Cummings

Koopman

. Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS. AIDS Care 2007; 19(2): 220–225.

14.

Gutteling

de Man

van der Plas

Schalm

Bussbach

Darlington

. Determinants of quality of life in chronic liver patients. Alimentary and Pharmacological Therapy 2006; 23(11): 1629–1635.

15.

Rowan

Al-Jurdi

Tavakoli-Tabasi

Kunik

Satrom

El-Serag

. Physical and psychosocial contributions to quality of life in veterans with hepatitis C not on antiretroviral therapy. Journal of Clinical Gastroenterology 2005; 39(8): 731–736.

16.

Foster

Goldin

Thomas

. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27(1): 209–212.

17.

Foster

. Hepatitis C virus infection: Quality of life and side effects of treatment. Journal of Hepatology 1999; 31(Suppl 1): 250–254.

18.

Hauser

Zimmer

Schiedermaier

Grandt

. Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosomatic Medicine 2004; 66(6): 954–958.

19.

Maggi

Giorgi

Fornai

Morrica

Vatteroni

Pistello

Siciliano

Nuccorini

Bendinelli

. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. Journal of Neurovirology 1999; 5(3): 319–323.

20.

Laskus

Radkowski

Adair

Wilkinson

Scheck

Rakela

. Emerging evidence of hepatitis C neuroinvasion. AIDS 2005; 19(Suppl 3): S140–S144.

21.

Forton

Taylor-Robinson

Thomas

. Central nervous system changes in hepatitis C virus infection. European Journal of Gastroenterology and Hepatology 2006; 18(4): 333–338.

22.

Cherner

Letendre

Heaton

Durelle

Marquie-Beck

Gragg

, Grant I, the HIV Neurobehavioral Research Center Group. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005; 64(8): 1343–1347.

23.

Forton

Taylor-Robinson

Thomas

. Cerebral dysfunction in chronic hepatitis C infection. Journal of Viral Hepatitis 2003; 10(2): 81–86.

24.

Perry

Hilsabeck

Hassanein

. Cognitive dysfunction in chronic hepatitis C: A review. Digestive Disease Science 2008; 53: 307–321.

25.

Hilsabeck

Perry

Hassanein

. Neuropsychological impairment in patients with hepatitis C. Hepatology 2002; 35(2): 440–446.

26.

McAndrews

Farcnik

Carlen

Damyanovich

Mrkonjic

Jones

Heathcote

. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41(4): 801–808.

27.

Dwight

Kowdley

Russo

Ciechanowski

Larson

Katon

. Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research 2000; 49(5): 311–317.

28.

Kramer

Hofer

Bauer

Funk

Formann

Steindl-Munda

Ferenci

. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS 2005; 19(Suppl 3): S85–S92.

29.

Lim

Cronkite

Goldstein

Cheung

. The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life. Journal of Clinical Gastroenterology 2006; 40(6): 528–534.

30.

Obhrai

Hall

Anand

. Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. Journal of Clinical Gastroenterology 2001; 32(5): 413–417.

31.

Wessely

Pariante

. Fatigue, depression, and chronic hepatitis C infection. Psychology and Medicine 2002; 32(1): 1–10.

32.

Engel

. The need for a new medical model: A challenge for biomedicine. Science 1977; 196(4286): 129–136.

33.

Musselman

Lawson

Gumnick

Manatunga

Penna

Goodkin

Greiner

Nemeroff

Miller

. Paroxetine for the prevention of depression induced by high-dose interferon alpha. New England Journal of Medicine 2001; 344(13): 961–966.

34.

Schaefer

Schwaiger

Garkisch

Pich

Hinzpeter

Uebelhack

Heinz

van Boemmel

Berg

. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. Journal of Hepatology 2005; 42(6): 793–798.

35.

Goldsmith

Mindrum

Myaing

. Psychiatric assessment of patients with hepatitis C virus before initiating interferon treatment. Psychiatric Annals 2003; 33(6): 369–376.

36.

Saunders

Cookman

. A clarified conceptual meaning of hepatitis C-related depression. Gastroenterology Nursing 2005; 28(2): 123–129.

37.

Raison

Broadwell

Borisov

Manatunga

Capuron

Woolwine

Jacobson

Nemeroff

Miller

. Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C. Brain Behavior and Immunology 2005; 19(1): 23–27.

38.

Raison

Borisov

Broadwell

Capuron

Woolwine

Jacobson

Nemeroff

Miller

. Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction. Journal of Clinical Psychiatry 2005; 66(1): 41–48.

39.

Pariante

Orru

Baita

Farci

Carpiniello

. Treatment with interferon alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999; 354(9173): 131–132.

40.

Renault

Hoofnagle

Park

Mullen

Peters

Jones

Rustgi

Jones

. Psychiatric complications of long-term interferon alfa therapy. Archives of Internal Medicine 1987; 147(9): 1577–1580.

41.

Gleason

Fucci

Yates

Philipsen

. Preventing relapse of major depression during interferon-alpha therapy for hepatitis C: A pilot study. Digestive Disease Science 2007; 52(10): 2557–2563.

42.

Dan

Crone

Wise

Martin

Ramsey

Magee

Sjogren

Ong

Younossi

. Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life. Psychosomatics 2007; 48(3): 223–229.

43.

Rodger

Jolley

Thompson

Lanigan

Crofts

. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30(5): 1299–1301.

44.

Carta

Hardoy

Garofalo

Pisano

Nonnoi

Intilla

Serra

Balestrieri

Chessa

Cauli

Lai

Farci

. Association of chronic hepatitis C with major depressive disorders: Irrespective of interferon-alpha therapy. Clinical Practice of Epidemiology and Mental Health 2007; 3: 22.

45.

Gutteling

de Man

Vusschbach

JJV

Darlington

ASE

. Health-related quality of life and psychological correlates in patients listed for liver transplantation. Hepatology International 2007; 1: 437–443.

46.

Ferenci

Staufer

. Depression in chronic hepatitis: The virus, the drug, or the ethnic background? Liver International 2008; 28(4): 429–431.

47.

Cormier

. The role of hepatitis C support groups. Gastroenterology Nursing 2005; 28(3 Suppl): S4–S9.